Cutter Capital Management, LP Royalty Pharma PLC Transaction History
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
A detailed history of Cutter Capital Management, LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cutter Capital Management, LP holds 692,300 shares of RPRX stock, worth $19.1 Million. This represents 5.51% of its overall portfolio holdings.
Number of Shares
692,300
Previous 411,540
68.22%
Holding current value
$19.1 Million
Previous $12.5 Billion
46.07%
% of portfolio
5.51%
Previous 4.78%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
397Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.22 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.05 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$634 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$450 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$330 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...